cancer du sein; inhibiteurs de l'aromatase; tamoxifene; hormonothérapie; oncologie; breast cancer; breast neoplasm; endocrine therapy; aromatase inhibitors; tamoxifen; oncology
Disciplines :
Oncology
Author, co-author :
LIFRANGE, Eric ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
ANDRE, Chantal ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
BLERET, Valerie ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
COLLIGNON, Joëlle ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
COUCKE, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
CUSUMANO, Giuseppe ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
DESREUX, Joëlle ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
HERMAN, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
KRIDELKA, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique
MARTIN, Marie
RORIVE, Andrée ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Van Cauwenberge, Jean-Rémy ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie-Obstétrique-Sénologie
Beatson GT. - On the treatment of inoperable cases of carcinoma of the mamma : suggestions for a new method of treatment with illustrative cases. Lancet, 1896, 148, 104-107.
Engelsman E, Persijn JP, Korsten CB, et al. - Oestrogen receptor in human breast cancer tissue and response to endocrine therapy. Br Med J, 1973, 2, 750-752.
Horwitz KB, Mc Guire WL. - Predicting response to endocrine therapy in human breast cancer : a hypothesis. Science, 1975, 189, 726-727
Osborne CK, Mc Guire WL. - The use of steroid hormone receptors in the treatment of human breast cancer: review. Bull Cancer, 1979, 66, 203-209. (Pubitemid 9201541)
Ward HW. - Antioestrogen therapy for breast cancer : a trial of tamoxifen at two dose levels. Br Med J, 1973, 1, 13-14.
Rose C, Thorpe SM, Lober J, et al. - Therapeutic effect of tamoxifen related to estrogen receptor level. Recent Results Cancer Res, 1980, 71, 134-141. (Pubitemid 10121392)
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). - Tamoxifen for early breast cancer : an overview of the randomised trials. Lancet, 1998, 351, 1451-1467.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). - Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival : an overview of the randomised trials. Lancet, 2005, 365, 1687-1717.
Goel S, Sharma R, Hamilton A, et al. - LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Cochrane Database Syst Rev, 2009, 7, 4, CD 004562.
Cuzick J, Sestak I, Baum M, et al. - Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer : 10-year analysis of the ATAC trial. Lancet Oncol, 2010, 11, 1135-1141.
Coombes RC, Kilburn LS, Snowdon CF, et al. - Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study) : a randomised controlled trial. Lancet, 2007, 369, 559-570.
BIG 1-98 Collaborative Group, Mouridsen H, Giobbie-Hurder A et al. - Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med, 2009, 361, 766-776.
Goss PE, Ingle JN, Martino S, et al. - Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer : updated findings from NCIC CTG MA 17. J Natl Cancer Inst, 2005, 97, 1262-1271. (Pubitemid 41535367)
Cuppone F, Bria E, Verma S, et al. - Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer ? Meta-analysis of randomized trials. Cancer, 2008, 112, 260-267.
Bleret V, Collignon J, Coucke P, et al. - L'observance au traitement de longue durée : le cas particulier de l'hormonothérapie adjuvante du cancer du sein. Rev Med Liège, 2010, 65, 405-408.
Desreux J, Bleret V, Pintiaux A, et al. - Prise en charge des conséquences de la carence oestrogénique après cancer du sein. Rev Med Liège, 2011, 66, 385-392.
Jordan VC. - Evolution of long-term adjuvant anti-hormone therapy : consequences and opportunities. Breast, 2011, 20, S1.
